Trial Profile

A Phase 2, Double-Blind, Placebo-Controlled, 3-Month Trial of LY3298176 Versus Placebo in Patients With Type 2 Diabetes Mellitus

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 15 Jun 2021

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Tirzepatide (Primary)
Indications Type 2 diabetes mellitus
Focus Therapeutic Use
Sponsors Eli Lilly and Company

Most Recent Events

11 Jun 2019 Results presented at the 79th Annual Scientific Sessions of the American Diabetes Association
08 Jun 2019 According to an Eli Lilly media release, results from this study were presented in oral and poster presentations at the American Diabetes Association's 79th Scientific Sessions.
08 Jun 2019 Results published in the Eli Lilly Media Release.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com